Epidemiology of neuropathic pain

what do we really know?

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

    Abstract

    Epidemiology is an important clinical tool in designing and evaluating management and prevention strategies, and is particularly relevant to neuropathic pain. However, there is a relative lack of accurate information available, for several good reasons, in one sense, neuropathic pain describes a symptom or a mechanism, rather than a specific disease. On the other hand, there are sufficient similarities in the effects and response to treatment between different causes to make it worthwhile considering neuropathic pain as a distinct condition. There are however important specific disease-based factors that need to be considered separately. Estimates of prevalence that are base on specific causes of neuropathic pain end to be lower (1% to 2%) than those that are based on reports of the classic symptoms (6% to 8%), and further methodological research is needed. All neuropathic pain is associated with poor general health, comparable with other severe chronic diseases. The importance of newly proposed risk factors, including genetic facros, is still to be assessed at a population level.

    Original languageEnglish
    Title of host publication3rd International Congress on Neuropathic Pain (Neupsig)
    EditorsCD Wells
    Place of Publication40128 BOLOGNA
    PublisherMedimond S R L
    Pages79-88
    Number of pages10
    ISBN (Print)978-88-7587-567-1
    Publication statusPublished - 2010
    Event3rd International Congress on Neuropathic Pain - Athens, Greece
    Duration: 27 May 201030 May 2010
    http://www2.kenes.com/neuropathic2010/Pages/home.aspx

    Conference

    Conference3rd International Congress on Neuropathic Pain
    Abbreviated titleNeuPSIG 2010
    CountryGreece
    CityAthens
    Period27/05/1030/05/10
    Internet address

    Cite this

    Smith, B. H. (2010). Epidemiology of neuropathic pain: what do we really know? In CD. Wells (Ed.), 3rd International Congress on Neuropathic Pain (Neupsig) (pp. 79-88). 40128 BOLOGNA: Medimond S R L.
    Smith, B. H. / Epidemiology of neuropathic pain : what do we really know?. 3rd International Congress on Neuropathic Pain (Neupsig). editor / CD Wells. 40128 BOLOGNA : Medimond S R L, 2010. pp. 79-88
    @inproceedings{8ba4e0ec22954355baab480f5bb97d1c,
    title = "Epidemiology of neuropathic pain: what do we really know?",
    abstract = "Epidemiology is an important clinical tool in designing and evaluating management and prevention strategies, and is particularly relevant to neuropathic pain. However, there is a relative lack of accurate information available, for several good reasons, in one sense, neuropathic pain describes a symptom or a mechanism, rather than a specific disease. On the other hand, there are sufficient similarities in the effects and response to treatment between different causes to make it worthwhile considering neuropathic pain as a distinct condition. There are however important specific disease-based factors that need to be considered separately. Estimates of prevalence that are base on specific causes of neuropathic pain end to be lower (1{\%} to 2{\%}) than those that are based on reports of the classic symptoms (6{\%} to 8{\%}), and further methodological research is needed. All neuropathic pain is associated with poor general health, comparable with other severe chronic diseases. The importance of newly proposed risk factors, including genetic facros, is still to be assessed at a population level.",
    author = "Smith, {B. H.}",
    year = "2010",
    language = "English",
    isbn = "978-88-7587-567-1",
    pages = "79--88",
    editor = "CD Wells",
    booktitle = "3rd International Congress on Neuropathic Pain (Neupsig)",
    publisher = "Medimond S R L",

    }

    Smith, BH 2010, Epidemiology of neuropathic pain: what do we really know? in CD Wells (ed.), 3rd International Congress on Neuropathic Pain (Neupsig). Medimond S R L, 40128 BOLOGNA, pp. 79-88, 3rd International Congress on Neuropathic Pain , Athens, Greece, 27/05/10.

    Epidemiology of neuropathic pain : what do we really know? / Smith, B. H.

    3rd International Congress on Neuropathic Pain (Neupsig). ed. / CD Wells. 40128 BOLOGNA : Medimond S R L, 2010. p. 79-88.

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

    TY - GEN

    T1 - Epidemiology of neuropathic pain

    T2 - what do we really know?

    AU - Smith, B. H.

    PY - 2010

    Y1 - 2010

    N2 - Epidemiology is an important clinical tool in designing and evaluating management and prevention strategies, and is particularly relevant to neuropathic pain. However, there is a relative lack of accurate information available, for several good reasons, in one sense, neuropathic pain describes a symptom or a mechanism, rather than a specific disease. On the other hand, there are sufficient similarities in the effects and response to treatment between different causes to make it worthwhile considering neuropathic pain as a distinct condition. There are however important specific disease-based factors that need to be considered separately. Estimates of prevalence that are base on specific causes of neuropathic pain end to be lower (1% to 2%) than those that are based on reports of the classic symptoms (6% to 8%), and further methodological research is needed. All neuropathic pain is associated with poor general health, comparable with other severe chronic diseases. The importance of newly proposed risk factors, including genetic facros, is still to be assessed at a population level.

    AB - Epidemiology is an important clinical tool in designing and evaluating management and prevention strategies, and is particularly relevant to neuropathic pain. However, there is a relative lack of accurate information available, for several good reasons, in one sense, neuropathic pain describes a symptom or a mechanism, rather than a specific disease. On the other hand, there are sufficient similarities in the effects and response to treatment between different causes to make it worthwhile considering neuropathic pain as a distinct condition. There are however important specific disease-based factors that need to be considered separately. Estimates of prevalence that are base on specific causes of neuropathic pain end to be lower (1% to 2%) than those that are based on reports of the classic symptoms (6% to 8%), and further methodological research is needed. All neuropathic pain is associated with poor general health, comparable with other severe chronic diseases. The importance of newly proposed risk factors, including genetic facros, is still to be assessed at a population level.

    M3 - Conference contribution

    SN - 978-88-7587-567-1

    SP - 79

    EP - 88

    BT - 3rd International Congress on Neuropathic Pain (Neupsig)

    A2 - Wells, CD

    PB - Medimond S R L

    CY - 40128 BOLOGNA

    ER -

    Smith BH. Epidemiology of neuropathic pain: what do we really know? In Wells CD, editor, 3rd International Congress on Neuropathic Pain (Neupsig). 40128 BOLOGNA: Medimond S R L. 2010. p. 79-88